Please find the attached copy of Outcome of Board Meeting
BATLIBOI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Batliboi Ltd's board approved unaudited standalone and consolidated financial results for Q2 and H1 FY26 (ended September 30, 2025). Standalone Q2 revenue from operations grew to Rs. 8,264.10 lakhs (up ~19% from Rs. 6,945.59 lakhs), but the company slipped into a net loss of Rs. 61.34 lakhs versus a profit of Rs. 575.24 lakhs in Q2 FY25, largely dragged by exceptional items of Rs. 289.06 lakhs. H1 FY26 standalone net profit collapsed to just Rs. 1.25 lakhs (from Rs. 195.19 lakhs). On a consolidated basis, H1 FY26 revenue rose modestly to Rs. 19,836.21 lakhs, but net profit fell to Rs. 563.33 lakhs from Rs. 854.93 lakhs, and operating cash flow turned negative at Rs. (42.10) lakhs versus a positive Rs. 550 lakhs earlier. The board also granted 3,05,000 ESOP stock options at Rs. 111 per share, noted the resignation of CFO Mr. Ghanshyam Chechani, and appointed Mr. Kapil Arora (ex-Welspun Enterprises) as the new CFO with immediate effect. Prior period numbers have been restated to reflect the amalgamation of Batliboi Environmental Engineering Ltd (appointed date April 1, 2023), and a new subsidiary Bioconserve Renewables Envirotech Pvt Ltd (51% holding) was incorporated in April 2025.
Weak Q2 standalone performance with a net loss and negative operating cash flow could pressure the stock, while the sudden CFO exit and management change add short-term uncertainty. The amalgamation restatement, new subsidiary, and 3.05 lakh ESOP grant dilute equity and may temper near-term sentiment despite the new CFO's strong 23-year finance background.